Use of PROTACS as molecular probes of angiogenesis

Paola Bargagna-Mohan; Sun Hee Baek; Hyosung Lee; Kyungbo Kim; Royce Mohan

doi:10.1016/j.bmcl.2005.04.008

Use of PROTACS as molecular probes of angiogenesis

Paola Bargagna-Mohan, Sun Hee Baek, Hyosung Lee, Kyungbo Kim, Royce Mohan

Pharmaceutical Sciences

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Abstract

Small molecules designed to specifically activate or inactivate protein functions have been useful to study biological processes. PROTACS are small molecule chimera which comprise a ligand and a peptide recognition motif for an E3 ligase. These novel reagents exploit the ubiquitin-mediated proteasome degradation pathway to target the ligand-bound protein for intracellular degradation. Here, we report that an estrogen receptor (ER)-targeting PROTACS that causes degradation of ER is able to potently inhibit endothelial cell differentiation in a three-dimensional angiogenic sprouting assay. These findings support the use of ER-targeting PROTACS as probes of angiogenesis.

Original language	English
Pages (from-to)	2724-2727
Number of pages	4
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	15
Issue number	11
DOIs	https://doi.org/10.1016/j.bmcl.2005.04.008
State	Published - Jun 2 2005

Bibliographical note

Funding Information:
We are grateful to the Department of Ophthalmology and Visual Sciences (University of Kentucky) for generous start-up funds to R.M. and the Kentucky Lung Cancer Research Program for financial support to K.K.

Keywords

Angiogenesis
Endothelial cell differentiation
Estrogen
PROTACS
Receptor

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/j.bmcl.2005.04.008

Cite this

@article{fa495f9aba3a447cac720322e16990aa,

title = "Use of PROTACS as molecular probes of angiogenesis",

abstract = "Small molecules designed to specifically activate or inactivate protein functions have been useful to study biological processes. PROTACS are small molecule chimera which comprise a ligand and a peptide recognition motif for an E3 ligase. These novel reagents exploit the ubiquitin-mediated proteasome degradation pathway to target the ligand-bound protein for intracellular degradation. Here, we report that an estrogen receptor (ER)-targeting PROTACS that causes degradation of ER is able to potently inhibit endothelial cell differentiation in a three-dimensional angiogenic sprouting assay. These findings support the use of ER-targeting PROTACS as probes of angiogenesis.",

keywords = "Angiogenesis, Endothelial cell differentiation, Estrogen, PROTACS, Receptor",

author = "Paola Bargagna-Mohan and Baek, {Sun Hee} and Hyosung Lee and Kyungbo Kim and Royce Mohan",

note = "Funding Information: We are grateful to the Department of Ophthalmology and Visual Sciences (University of Kentucky) for generous start-up funds to R.M. and the Kentucky Lung Cancer Research Program for financial support to K.K.",

year = "2005",

month = jun,

day = "2",

doi = "10.1016/j.bmcl.2005.04.008",

language = "English",

volume = "15",

pages = "2724--2727",

number = "11",

}

TY - JOUR

T1 - Use of PROTACS as molecular probes of angiogenesis

AU - Bargagna-Mohan, Paola

AU - Baek, Sun Hee

AU - Lee, Hyosung

AU - Kim, Kyungbo

AU - Mohan, Royce

N1 - Funding Information: We are grateful to the Department of Ophthalmology and Visual Sciences (University of Kentucky) for generous start-up funds to R.M. and the Kentucky Lung Cancer Research Program for financial support to K.K.

PY - 2005/6/2

Y1 - 2005/6/2

N2 - Small molecules designed to specifically activate or inactivate protein functions have been useful to study biological processes. PROTACS are small molecule chimera which comprise a ligand and a peptide recognition motif for an E3 ligase. These novel reagents exploit the ubiquitin-mediated proteasome degradation pathway to target the ligand-bound protein for intracellular degradation. Here, we report that an estrogen receptor (ER)-targeting PROTACS that causes degradation of ER is able to potently inhibit endothelial cell differentiation in a three-dimensional angiogenic sprouting assay. These findings support the use of ER-targeting PROTACS as probes of angiogenesis.

AB - Small molecules designed to specifically activate or inactivate protein functions have been useful to study biological processes. PROTACS are small molecule chimera which comprise a ligand and a peptide recognition motif for an E3 ligase. These novel reagents exploit the ubiquitin-mediated proteasome degradation pathway to target the ligand-bound protein for intracellular degradation. Here, we report that an estrogen receptor (ER)-targeting PROTACS that causes degradation of ER is able to potently inhibit endothelial cell differentiation in a three-dimensional angiogenic sprouting assay. These findings support the use of ER-targeting PROTACS as probes of angiogenesis.

KW - Angiogenesis

KW - Endothelial cell differentiation

KW - Estrogen

KW - PROTACS

KW - Receptor

UR - http://www.scopus.com/inward/record.url?scp=19544366774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19544366774&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2005.04.008

DO - 10.1016/j.bmcl.2005.04.008

M3 - Article

C2 - 15876533

AN - SCOPUS:19544366774

SN - 0960-894X

VL - 15

SP - 2724

EP - 2727

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

IS - 11

ER -

Use of PROTACS as molecular probes of angiogenesis

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this